These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36244883)
1. Implementing a collaborative practice agreement for HIV pre-exposure prophylaxis in the primary care setting. Lee LC; Pollak BA; Coffey CP J Am Pharm Assoc (2003); 2023; 63(1):383-388. PubMed ID: 36244883 [TBL] [Abstract][Full Text] [Related]
2. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health. Lopez MI; Cocohoba J; Cohen SE; Trainor N; Levy MM; Dong BJ J Am Pharm Assoc (2003); 2020; 60(1):138-144. PubMed ID: 31405804 [TBL] [Abstract][Full Text] [Related]
3. Attitudes about community pharmacy access to HIV prevention medications in California. Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097 [TBL] [Abstract][Full Text] [Related]
4. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy. Lutz S; Heberling M; Goodlet KJ J Am Pharm Assoc (2003); 2021; 61(2):e75-e79. PubMed ID: 33069595 [TBL] [Abstract][Full Text] [Related]
5. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis. Farmer EK; Koren DE; Cha A; Grossman K; Cates DW AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124 [TBL] [Abstract][Full Text] [Related]
6. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care. Tung EL; Thomas A; Eichner A; Shalit P Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342 [TBL] [Abstract][Full Text] [Related]
7. Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States. Chandra C; Hudson AF; Alohan DI; Young HN; Crawford ND Curr HIV/AIDS Rep; 2024 Aug; 21(4):197-207. PubMed ID: 38775937 [TBL] [Abstract][Full Text] [Related]
8. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis. Shaeer KM; Sherman EM; Shafiq S; Hardigan P J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624 [TBL] [Abstract][Full Text] [Related]
9. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state. Unni EJ; Lian N; Kuykendall W J Am Pharm Assoc (2003); 2016; 56(5):527-532.e1. PubMed ID: 27594106 [TBL] [Abstract][Full Text] [Related]
10. Impact of a clinical pharmacist within an HIV PrEP program for patients experiencing homelessness. McElyea J; Bistransin K; Bana S; Alvarez KS; Brown LS; Persaud D; King H J Am Pharm Assoc (2003); 2023; 63(1):324-329. PubMed ID: 36184385 [TBL] [Abstract][Full Text] [Related]
11. Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States. Havens JP; Scarsi KK; Sayles H; Klepser DG; Swindells S; Bares SH Open Forum Infect Dis; 2019 Oct; 6(10):. PubMed ID: 31412131 [TBL] [Abstract][Full Text] [Related]
12. Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review. Zhao A; Dangerfield DT; Nunn A; Patel R; Farley JE; Ugoji CC; Dean LT AIDS Behav; 2022 May; 26(5):1377-1392. PubMed ID: 34669062 [TBL] [Abstract][Full Text] [Related]
13. Assessing the use of an infographic on pre-exposure prophylaxis for Wisconsin community pharmacists. Tidd M; Shiyanbola O; Ford JH; Richert L J Am Pharm Assoc (2003); 2022; 62(6):1897-1903.e4. PubMed ID: 35989150 [TBL] [Abstract][Full Text] [Related]
14. Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention. Zhu V; Tran D; Banjo O; Onuegbu R; Seung H; Layson-Wolf C J Am Pharm Assoc (2003); 2020; 60(6):781-788.e2. PubMed ID: 32305210 [TBL] [Abstract][Full Text] [Related]
15. Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV. Broekhuis JM; Scarsi KK; Sayles HR; Klepser DG; Havens JP; Swindells S; Bares SH PLoS One; 2018; 13(11):e0207372. PubMed ID: 30427912 [TBL] [Abstract][Full Text] [Related]
16. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health. Okoro O; Hillman L J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257 [TBL] [Abstract][Full Text] [Related]
17. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss! Lopez MI; Grant RM; Dong BJ J Am Pharm Assoc (2003); 2020; 60(4):e18-e24. PubMed ID: 32165026 [TBL] [Abstract][Full Text] [Related]
18. Expanding expedited partner therapy and HIV prophylaxis in the emergency department. Mercer KJ; Brizzi MB; Burhoe DN; Senn JM; Rohani R; Nowicki DN; Januszka JE; Wordlaw R; Durham SH Am J Health Syst Pharm; 2024 Apr; 81(8):279-290. PubMed ID: 38142223 [TBL] [Abstract][Full Text] [Related]
19. Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation. Zewdie KB; Ngure K; Mwangi M; Mwangi D; Maina S; Etyang L; Maina G; Ogello V; Owidi E; Mugo NR; Baeten JM; Mugwanya KK J Int AIDS Soc; 2024 Mar; 27(3):e26222. PubMed ID: 38446643 [TBL] [Abstract][Full Text] [Related]
20. Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP). Meyerson BE; Dinh PC; Agley JD; Hill BJ; Motley DN; Carter GA; Jayawardene W; Ryder PT AIDS Behav; 2019 Jul; 23(7):1925-1938. PubMed ID: 30607758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]